ABG-WTT Global Life Science Capital Partners GP Ltd — Q3 2024 13F-HR

← ABG-WTT Global Life Science Capital Partners GP Ltd

Q3 2024 · 13F-HR

ABG-WTT Global Life Science Capital Partners GP Ltdholdings as filed

Filed 2024-11-14 · accession 0000950123-24-011466

$20.1M

Reported value

Positions

2024-09-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
156944100	CGON	CG ONCOLOGY INC	$18.7M	92.9%	495,526	Common	SOLE
75340L104	RPID	RAPID MICRO BIOSYSTEMS INC	$924,083	4.59%	1,038,296	Common	SOLE
745848101	LUNG	PULMONX CORP	$499,091	2.48%	60,204	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.